Why Two Seas Capital Opposes Core Scientific’s $9B Sale

Two Seas Capital is pushing back against Core Scientific’s $9B sale to CoreWeave, claiming it’s a risky deal. Will shareholders...

08/08/2025

2 views

Mastering M&A: Types, Strategies, and Valuations

Ever wondered how companies join forces or take over rivals? Dive into the world of M&A to uncover strategies and...

04/05/2025

1 views

Ever wondered what market cap really tells you about a company? Dive into our guide to uncover its secrets and...

30/04/2025

0 views